Jens Niewoehner

1.4k total citations · 1 hit paper
19 papers, 969 citations indexed

About

Jens Niewoehner is a scholar working on Molecular Biology, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jens Niewoehner has authored 19 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Physiology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jens Niewoehner's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Erythrocyte Function and Pathophysiology (3 papers) and Alzheimer's disease research and treatments (3 papers). Jens Niewoehner is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Erythrocyte Function and Pathophysiology (3 papers) and Alzheimer's disease research and treatments (3 papers). Jens Niewoehner collaborates with scholars based in Switzerland, Germany and United States. Jens Niewoehner's co-authors include Per‐Ola Freskgård, Hadassah Sade, Eduard Urich, Petra Rueger, Bernd Bohrmann, Hansruedi Loetscher, Wilma Lau, Peter Maier, Ludovic Collin and Alain C. Tissot and has published in prestigious journals such as Neuron, PLoS ONE and Neurology.

In The Last Decade

Jens Niewoehner

18 papers receiving 950 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle

2014 438 citations Jens Niewoehner, Bernd Bohrmann et al. Neuron profile →

Peers

Countries citing papers authored by Jens Niewoehner

Since Specialization

Citations

This map shows the geographic impact of Jens Niewoehner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Niewoehner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Niewoehner more than expected).

Fields of papers citing papers by Jens Niewoehner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Niewoehner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Niewoehner. The network helps show where Jens Niewoehner may publish in the future.

Co-authorship network of co-authors of Jens Niewoehner

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Niewoehner. A scholar is included among the top collaborators of Jens Niewoehner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Niewoehner. Jens Niewoehner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Pretargeted Immuno-PET Enables Monoclonal Antibody Imaging Beyond the Blood–Brain Barrier 2025 ·Molecular Pharmaceutics ·Tobias Gustavsson, Thomas Kustermann, (unknown), (unknown), (unknown), (unknown), Vladimir Shalgunov, (unknown), Gitte M. Knudsen, Blanca I. Aldana, (unknown), Giuseppe Cannazza, Jens Niewoehner, Luca Gobbi, Michael Honer, Umberto Maria Battisti, Andreas Kjær, Matthias M. Herth	0
2	A microfluidic bone marrow chip for the safety profiling of biologics in pre-clinical drug development 2025 ·Communications Biology ·(unknown), (unknown), (unknown), Susanne Fischer, (unknown), Sabine Imhof-Jung, (unknown), (unknown), Daniel Marbach, Jens Niewoehner, Annika Winter, Dirk Schubert	2
3	Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans 2023 ·mAbs ·Hans Peter Grimm, Vanessa Schumacher, Martin Schäfer, Sabine Imhof-Jung, Per‐Ola Freskgård, Kevin Brady, Carsten Hofmann, (unknown), Tilman Schlothauer, Ulrich Göpfert, Maximilian J. Hartl, (unknown), (unknown), (unknown), (unknown), Jens Niewoehner, (unknown)	68
4	Circular RNAs With Efficacy in PreclinicalIn VitroandIn VivoModels of Esophageal Squamous Cell Carcinoma 2022 ·Cancer Genomics & Proteomics ·Ulrich H. Weidle, (unknown), Ulrich Brinkmann, Jens Niewoehner	7
5	Investigating receptor-mediated antibody transcytosis using blood–brain barrier organoid arrays 2021 ·Fluids and Barriers of the CNS ·(unknown), (unknown), (unknown), Nathalie Brandenberg, Sylke Hoehnel, Camilla Ceroni, (unknown), Elena Kassianidou, Hendrik Knoetgen, Jens Niewoehner, Roberto Villaseñor	38
6	Brain Shuttle Neprilysin reduces central Amyloid-β levels 2020 ·PLoS ONE ·Christopher Campos, (unknown), Jens Niewoehner, Per‐Ola Freskgård, Eduard Urich	28
7	Brain Shuttle Antibody for Alzheimer’s Disease with Attenuated Peripheral Effector Function due to an Inverted Binding Mode 2018 ·Cell Reports ·Felix Weber, Bernd Bohrmann, Jens Niewoehner, Jens A. A. Fischer, Petra Rueger, Georg Tiefenthaler, (unknown), Alexander Bujotzek, Kevin Brady, Thomas P. Singer, Martin Ebeling, Antonio Iglesias, Per‐Ola Freskgård	66
8	First Infusion Reactions are Mediated by FcγRIIIb and Neutrophils 2018 ·Pharmaceutical Research ·Felix Weber, (unknown), (unknown), Claas A. Meyer, Jens Niewoehner, Martin Ebeling, Per‐Ola Freskgård, Peter Bruenker, Thomas P. Singer, Michael Reth, Antonio Iglesias	10
9	Potent and Selective BACE-1 Peptide Inhibitors Lower Brain Aβ Levels Mediated by Brain Shuttle Transport 2017 ·EBioMedicine ·Nadine Ruderisch, Daniel Schlatter, A. Kuglstatter, Wolfgang Guba, Sylwia Huber, Carlo Cusulin, Jörg Benz, Arne C. Rufer, Joerg Hoernschemeyer, Christophe Schweitzer, (unknown), (unknown), Eike Hoffmann, Jens Niewoehner, Christoph Patsch, Karlheinz Baumann, Hansruedi Loetscher, Eric Kitas, Per‐Ola Freskgård	23
10	A comparative study of binding properties of gantenerumab and aducanumab analog to aggregated amyloid-beta (P6.087) 2017 ·Neurology ·Bernd Bohrmann, (unknown), Viviane Anquez, Karlheinz Baumann, Eric A. Kusznir, Françoise Gerber, Jürg Messer, Sylwia Huber, Jens Niewoehner, W. Richter, Georg Tiefenthaler	2
11	Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle breakdown → 2014 ·Neuron ·Jens Niewoehner, Bernd Bohrmann, Ludovic Collin, Eduard Urich, Hadassah Sade, Peter Maier, Petra Rueger, Jan Olaf Stracke, Wilma Lau, Alain C. Tissot, Hansruedi Loetscher, Anirvan Ghosh, Per‐Ola Freskgård	438
12	A Human Blood-Brain Barrier Transcytosis Assay Reveals Antibody Transcytosis Influenced by pH-Dependent Receptor Binding 2014 ·PLoS ONE ·Hadassah Sade, Claudia Baumgartner, (unknown), Ekkehard Moessner, Per‐Ola Freskgård, Jens Niewoehner	113
13	Time to Open the Blood–Brain Barrier Gate for Biologics? 2014 ·Future Neurology ·Per‐Ola Freskgård, Jens Niewoehner, Eduard Urich	7
14	Crystal Structure of Human TWEAK in Complex with the Fab Fragment of a Neutralizing Antibody Reveals Insights into Receptor Binding 2013 ·PLoS ONE ·Alfred Lammens, Monika Baehner, Ulrich Kohnert, Jens Niewoehner, (unknown), (unknown), Katja Lammens, Karl‐Peter Hopfner	19
15	Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma 2013 ·Journal of Allergy and Clinical Immunology ·Donavan T. Cheng, X. Cynthia, Jens Niewoehner, Martin E. Dahl, Angela Tsai, Jun Zhang, Waldemar Gonsiorek, Subbu Apparsundaram, Achal Pashine, Palanikumar Ravindran, (unknown), Julie Q. Hang, John Allard, Hans Bitter, Catherine Tribouley, Satwant K. Narula, Stephen Wilson, María E. Fuentes	42
16	TL1A/TNFSF15 directly induces proinflammatory cytokines, including TNFα, from CD3+CD161+ T cells to exacerbate gut inflammation 2012 ·Mucosal Immunology ·(unknown), Jia En Chin, S Seeber, Jens Niewoehner, Barbara Weiser, Nicola Beaucamp, Jennifer Woods, C. Murphy, Á Fanning, Fergus Shanahan, Kenneth Nally, Radhika Kajekar, Azucena Salas, Núria Planell, Juan José Lozano, Julián Panés, H. Parmar, Julie A. DeMartino, S K Narula, (unknown)	57
17	Expression and localization of claudins-3 and -12 in transformed human brain endothelium 2012 ·Fluids and Barriers of the CNS ·Anja Schrade, Hadassah Sade, Pierre‐Olivier Couraud, Ignacio A. Romero, Babette B. Weksler, Jens Niewoehner	43
18	Expression and localization of claudins-3 and -12 in transformed human brain endothelium 2012 ·Fluids and Barriers of the CNS ·Anja Schrade, Hadassah Sade, Pierre‐Olivier Couraud, Ignacio A. Romero, Babette B. Weksler, Jens Niewoehner	1
19	Anti-TSLPR Antibody RG7258 Blocks Dendritic Cell Activation, Mast Cell Cytokine Release And Reduces Th2 Inflammation In A Non-Human Primate Model Of Allergic Lung Inflammation 2011 ·María E. Fuentes, (unknown), Jun Zhang, Achal Pashine, Subbu Apparsundaram, Stephen J. Wilson, Jens Niewoehner	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact